Because of the general success of the artemisinin-based anti-malarials, there have been several combinations evaluated. As mentioned previously, the artemether and lumefantrine combination has been approved. Undergoing phase III studies is a pyronaridine (Fig. 7.5) and artesunate (Fig. 7.6). Pyronaridine inhibits formation of hematin, possibly by a similar mechanism to that of chloroquine.29
Pyruvic Acid +
Was this article helpful?